Sanjivani Paranteral [SANJIVIN] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Sanjivani Paranteral

BSE

Aarti Drugs

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanjivani Paranteral wins in 8 metrics, Aarti Drugs wins in 10 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Sanjivani Paranteral	Aarti Drugs	Better
P/E Ratio (TTM)	32.24	22.81	Aarti Drugs
Price-to-Book Ratio	6.71	3.14	Aarti Drugs
Debt-to-Equity Ratio	20.42	44.92	Sanjivani Paranteral
PEG Ratio	N/A	0.36	N/A
EV/EBITDA	24.84	16.76	Aarti Drugs
Profit Margin (TTM)	11.34%	7.80%	Sanjivani Paranteral
Operating Margin (TTM)	13.88%	10.11%	Sanjivani Paranteral
EBITDA Margin (TTM)	13.88%	10.11%	Sanjivani Paranteral
Return on Equity	20.30%	12.28%	Sanjivani Paranteral
Return on Assets (TTM)	10.35%	6.53%	Sanjivani Paranteral
Free Cash Flow (TTM)	$-179.46M	$674.20M	Aarti Drugs
Dividend Yield	N/A	0.22%	N/A
1-Year Return	-27.22%	-14.34%	Aarti Drugs
Price-to-Sales Ratio (TTM)	3.69	1.77	Aarti Drugs
Enterprise Value	$2.62B	$49.56B	Aarti Drugs
EV/Revenue Ratio	3.66	2.05	Aarti Drugs
Gross Profit Margin (TTM)	48.33%	36.77%	Sanjivani Paranteral
Revenue per Share (TTM)	$61	$265	Aarti Drugs
Earnings per Share (Diluted)	$6.66	$20.65	Aarti Drugs
Beta (Stock Volatility)	-0.82	0.21	Sanjivani Paranteral

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Sanjivani Paranteral vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Sanjivani Paranteral	-2.19%	-1.12%	-11.65%	-2.46%	-25.72%	-44.39%
Aarti Drugs	2.56%	-4.13%	-10.00%	1.76%	27.10%	6.05%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Sanjivani Paranteral	-27.22%	333.27%	2,293.46%	994.33%	366.08%	143.88%
Aarti Drugs	-14.34%	10.27%	-34.08%	237.25%	2,680.94%	2,426.41%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Sanjivani Paranteral (SANJIVIN): View Full Stock Overview

Aarti Drugs (AARTIDRUGS): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Sanjivani Paranteral vs Aarti Drugs

Metric	SANJIVIN	AARTIDRUGS
Market Information
Market Cap i	₹2.64B	₹42.99B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	3,528	149,023
90 Day Avg. Volume i	7,954	593,839
Last Close	₹212.30	₹483.05
52 Week Range	₹203.10 - ₹396.95	₹312.00 - ₹635.00
% from 52W High	-46.52%	-23.93%
All-Time High	₹396.95 (Dec 30, 2024)	₹1,026.95 (Oct 05, 2020)
% from All-Time High	-46.52%	-52.96%
Growth Metrics
Quarterly Revenue Growth	0.09%	0.06%
Quarterly Earnings Growth	0.01%	0.62%
Financial Health
Profit Margin (TTM) i	0.11%	0.08%
Operating Margin (TTM) i	0.14%	0.10%
Return on Equity (TTM) i	0.20%	0.12%
Debt to Equity (MRQ) i	20.42	44.92
Cash & Liquidity
Book Value per Share (MRQ)	₹31.98	₹149.84
Cash per Share (MRQ)	₹2.04	₹2.48
Operating Cash Flow (TTM) i	₹35.93M	₹2.83B
Levered Free Cash Flow (TTM) i	₹80.94M	₹1.68B
Dividends
Last 12-Month Dividend Yield i	N/A	0.22%
Last 12-Month Dividend i	N/A	₹1.00

Valuation & Enterprise Metrics Analysis: Sanjivani Paranteral vs Aarti Drugs

Metric	SANJIVIN	AARTIDRUGS
Price Ratios
P/E Ratio (TTM) i	32.24	22.81
Forward P/E i	N/A	14.86
PEG Ratio i	N/A	0.36
Price to Sales (TTM) i	3.69	1.77
Price to Book (MRQ) i	6.71	3.14
Market Capitalization
Market Capitalization i	₹2.64B	₹42.99B
Enterprise Value i	₹2.62B	₹49.56B
Enterprise Value Metrics
Enterprise to Revenue i	3.66	2.05
Enterprise to EBITDA i	24.84	16.76
Risk & Other Metrics
Beta i	-0.82	0.21
Book Value per Share (MRQ) i	₹31.98	₹149.84

Financial Statements Comparison: Sanjivani Paranteral vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SANJIVIN	AARTIDRUGS
Revenue/Sales i	₹178.92M	₹6.77B
Cost of Goods Sold i	₹111.14M	₹4.37B
Gross Profit i	₹67.78M	₹2.40B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹24.84M	₹784.50M
EBITDA i	₹26.83M	₹951.90M
Pre-Tax Income i	₹23.01M	₹711.50M
Income Tax i	₹5.70M	₹83.80M
Net Income (Profit) i	₹17.31M	₹627.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SANJIVIN	AARTIDRUGS
Cash & Equivalents i	₹14.85M	₹45.80M
Total Current Assets i	₹341.80M	₹13.38B
Total Current Liabilities i	₹317.92M	₹8.37B
Long-Term Debt i	₹52.89M	₹2.86B
Total Shareholders Equity i	₹398.71M	₹13.69B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹205.64M	₹8.59B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SANJIVIN	AARTIDRUGS
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SANJIVIN	AARTIDRUGS
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	3,528	149,023
Average Daily Volume (90 Day) i	7,954	593,839
Shares Outstanding i	11.88M	91.27M
Float Shares i	5.73M	35.46M
% Held by Insiders i	0.55%	0.61%
% Held by Institutions i	0.01%	0.11%

Dividend Analysis & Yield Comparison: Sanjivani Paranteral vs Aarti Drugs

Metric	SANJIVIN	AARTIDRUGS
Last 12-Month Dividend i	N/A	₹1.00
Last 12-Month Dividend Yield i	N/A	0.22%
3-Year Avg Annual Dividend i	N/A	₹1.00
3-Year Avg Dividend Yield i	N/A	0.23%
3-Year Total Dividends i	N/A	₹3.00
Ex-Dividend Date	N/A	Feb 04, 2025

Sanjivani Paranteral [SANJIVIN] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison